Free Trial

Organigram (TSE:OGI) Stock Price Up 0.5% - What's Next?

Organigram logo with Medical background

Organigram Holdings Inc. (TSE:OGI - Get Free Report) was up 0.5% during trading on Thursday . The company traded as high as C$1.94 and last traded at C$1.91. Approximately 40,131 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 189,429 shares. The stock had previously closed at C$1.90.

Organigram Trading Down 0.5%

The stock has a fifty day moving average of C$1.80 and a 200 day moving average of C$1.82. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. The company has a market capitalization of C$234.73 million, a PE ratio of -4.02, a PEG ratio of 0.42 and a beta of 1.13.

About Organigram

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

Featured Stories

Should You Invest $1,000 in Organigram Right Now?

Before you consider Organigram, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.

While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines